INNOVATIVE KEYS TO
HEALTH AND WELLBEING
New marketing authorization for indication newly diagnosed DIPG, recurrent/refractory DIPG, locally advanced or metastatic pancreatic cancer is approved in Chile.
Innokeys | March 29th, 2018